4
Changes in Ownership
Roivant Sciences Ltd. Filed Acc 0000950170-24-109731
Director sold 4,426,000 shares at an average $11.71 ($51,820,727)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Gold Daniel Allen Director | 2024-09-24 | Sale | −1,565,670 | $11.63 | $18,200,914 | 5,723,423 | D |
| Gold Daniel Allen Director | 2024-09-24 | Sale | −577,186 | $11.63 | $6,709,787 | 2,079,059 | I |
| Gold Daniel Allen Director | 2024-09-25 | Sale | −991,593 | $11.77 | $11,666,389 | 4,731,830 | D |
| Gold Daniel Allen Director | 2024-09-25 | Sale | −365,551 | $11.77 | $4,300,817 | 1,713,508 | I |
| Gold Daniel Allen Director | 2024-09-25 | Sale | −50,000 | $11.77 | $588,500 | 23,055,358 | I |
| Gold Daniel Allen Director | 2024-09-26 | Sale | −876,000 | $11.82 | $10,354,320 | 22,179,358 | I |
| Open-market sales · 4,426,000 sh · avg $11.71 · $51,820,727 | |||||||
Loading xslF345X05/ownership.xml…